Infection with rat cytomegalovirus (CMV) in the immunocompromised host is associated with the appearance of a T cell population with reduced CD8 and t cell receptor (TCR) expression

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 349-357

  Van Dam, J G ^a   Damoiseaux, J G M C ^a   Van der Heijden, H A M D ^a   Grauls, G ^a   Van Breda Vriesman, P J C ^a   Bruggeman, C A ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood leucocytes; Cytomegalovirus; Immunosuppression; Induction; Peripheral; Tolerance

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL; TISSUE DISTRIBUTION; VIRUS DETECTION;

EID: 0030862289     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4321449.x     Document Type: Article

References (48)

1. Grattan M, Moreno-Cabral C, Starnes V et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261:3561-6.
2. Zhou Y, Leon M, Waclawiw M et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335:624-30.
3. Speir E, Moduli R, Huang E et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265:391-4.
4. Ahn K, Angulo A, Ghazel P et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 1996; 93:10990-5.
5. Jones T, Wiertz E, Sun L et al. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 1996; 93:11327-33.
6. Thale R, Szepan U, Hengel H et al. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol 1995; 69:6098-105.
7. Wiertz E, Jones T, Sun L et al. The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmatic reticulum to the cytosol. Cell 1996; 84:769-79.
8. Ljunggren H, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-44.
9. Farrell H, Vally H, Lynch D et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997; 286:510-4.
10. Reyburn H, Mandelboim O, Vales-Gomez, M et al. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997; 386:514-7.
11. Bruggeman C, Debie W, Grauls G et al. Infection of laboratory rats with a new Cytomegalo-like virus. Arch Virol 1983; 76:189-99.
12. Bruggeman C, Meijer H, Bosman F et al. Biology of rat cytomegalovirus infection. Intervirology 1985; 24:1-9.
13. Li F, Grauls G, Yin M et al. Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis. Transplant Proc 1995; 27:3552-4.
14. Li F, Grauls G, Yin M et al. Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aorta allografts. Transplant Int 1996; 9:S1-S5.
15. Price P, Olver S. Animal models of human immunopathological disease syndromes induced by cytomegalovirus infection. Clin Immunol Immunopathol 1996; 80:215-24.
16. Bruggeman C, Li F, Stals F. Pathogenicity: animal models. Scand J Infect Dis 1995; 99:43-50.
17. Stals F, Bosman F, van Boven C et al. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol 1990; 114:91-107.
18. Rehbinder C, Baneux P, DF et al. FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guineapig and rabbit experimental units. Lab Anim 1996; 30:193-208.
19. Bruning J, Bruggeman C, Van Boven C et al. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplan 1986; 41:695-8.
20. Damoiseaux J, Beijleveld L, Van Breda Vriesman P. Cutaneous immunopathology of cyclosporin-A-induced autoimmunity in the rat. Clin Immunol Immunopathol 1995; 77:315-23.
21. Torres-Nagel N, Kraus E, Brown M et al. Differential thymus dependence of rat CD8 isoform expression. Eur J Immunol 1992; 22:2841-8.
22. Hunig T, Wallny H, Hartley J et al. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J Exp Med 1989; 169:73-86.
23. Dijkstra C, Dopp E, Joling P et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunol 1985; 54:589-99.
24. Chambers W, Vujanovic N, DeLeo A et al. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 1989; 169:1373-89.
25. Bruning J, Debie W, Dormans P et al. The development and character- ization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 1987; 94:55-70.
26. Bruggeman C, Meijer H, Dormans P et al. Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 1982; 73:231-41.
27. Beuken H, Slobbe R, Bruggeman CA et al. Cloning and sequence analysis of the genes encoding DNA polymerase, glycoprotein B, ICP18.5 and major DNA-binding protein of rat cytomegalovirus. J Gen Virol 1996; 77:1559-62.
28. Beijleveld LJJ, Groen H, Broeren CPM et al. Susceptibility to clinically manifest cyclosporine A (CsA)-induced autoimmune disease is associated with interferon-gamma (IFN-gamma)-producing CD45RC' RT6 T helper cells. Clin Exp Immunol 1996; 105:486-96.
29. Bellgrau D, Lagarde A. Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire. Proc Natl Acad Sci USA 1990; 87:313-7.
30. Schonrich G, Kalinke U, Momburg F et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65:293-304.
31. Zhang L. The fate of adoptively transferred antigen-specific T cells in vivo. Eur J Immunol 1996; 26:2208-14.
32. Doody D, Wilson E, Medearis D et al. Changes in the phenotype of T-cell subset determinants following murine cytomegalovirus infection. Clin Immunol Immunopathol 1986; 40:466-75.
33. Reddehase M, Mutter W, Munch K et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61:3102-8.
34. + lymphocyte depletion on acute murine cytomegalovirus infection. J Gen Virol 1989; 70:1765-71.
35. Shanley J. In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection. J Med Virol 1990; 30:58-60.
36. Welsh R, Brubaker J, Vargas Cortes M et al. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 1991; 173:1053-63.
37. Carney W, Rubin R, Hoffman R et al. Analysis of lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 1981; 126:2114-6.
38. + cytotoxic T lymphocytes in bone marrow recipients. Bone Marrow Transplant 1996; 18:339-45.
39. Li C, Greenberg P, Gilbert M et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83:1971-9.
40. Riddell S, Reusser P, Greenberg P. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients. Rev Infect Dis 1991; 13 (Suppl. 11):S966-73.
41. Van den Berg A, Van Son W, Janssen R et al. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes. J Infect Dis 1992; 166:1228-35.
42. Quinnan G, Kirmani N, Rook A et al. Cytotoxic T cells in cytomegalovirus infection. HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytopmegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307:7-13.
43. Bruning J, Bruggeman C, Van Breda Vriesman P. The transfer of cytomegalovirus infection in rats by latently infected renal allografts, and the role of various immunosuppressive regimens in virus reactivation. Transplant 1988; 46:623-4.
44. Reddehase M, Balthesen M, Rapp M et al. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994; 179:185-93.
45. Balthesen M, Messerle M, Reddehase M. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67:5360-6.
46. Balthesen M, Dreher L, Lucin P et al. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J Gen Virol 1994; 75:2329-36.
47. Bevan D, Chisholm P. Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T-cells. Immunol 1986; 59:621-5.
48. Schwartz R. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996; 184:1-8.